CONSORTIUM FOR DEVELOPING REGULATORY CAPACITY FOR CLINICAL TRIALS USING GENE THERAPY PRODUCTS AND STRENGTHENING PHARMACOVIGILANCE IN THE CONDUCT OF CLINICAL TRIALS IN EAST AFRICA

Project Information

CAPACITY 2023

Grant agreement ID: 101145599

DOI

10.3030/101145599

EC signature date 22 March 2024

Start date 1 April 2024

End date 31 March 2027

Funded under

• Health

Total cost

€ 999 315,35

EU contribution

€ 999 315,35

Coordinated by

UNIVERSIDADE DE COIMBRA
Portugal

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (1)

Extracellular vesicles-associated AAVs for the treatment of Machado-Joseph disease

Author(s): Carina Henriques, Patrícia Albuquerque, David Rufino-Ramos, Miguel M. Lopes, Kevin Leandro, Catarina O. Miranda, Rita Almeida, Guilherme Lopes-Gabriel, João de Sousa-Lourenço, Sara M. Lopes, Laetit
Published in: Molecular Therapy, Issue 34, 2026, ISSN 1525-0016
Publisher: Elsevier BV
DOI: 10.1016/J.YMTHE.2025.10.022